Pacira Pharmaceuticals Pays $3.5M to Settle Allegations of Using Grants as Kickbacks

Published date06 August 2020
Subject MatterKickbacks,Pharmaceutical Industry,DOJ,Anti-Kickback Statute,OIG
AuthorNicholas Klinefeldt,Jessica Barth,Gary Rom
Law FirmFaegre Drinker Biddle & Reath LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT